ARES LIFE SCIENCES
Ares Life Sciences AG is a venture capital firm specializing in expansion and late stage investments. The firm seeks to invest in life sciences sector with a focus on pharmaceuticals, biotechnology, diagnostics, medical technology, and healthcare services. In pharmaceuticals, it seeks to invest in innovative drugs, generics, and specialty to OTC. In biotechnology, it seeks to invest in in novel biological products and biosimilars.
ARES LIFE SCIENCES
Industry:
Venture Capital
Founded:
2008-01-01
Status:
Active
Contact:
+41 58 944 04 00
Similar Organizations
Freigeist Capital
Freigeist is a venture capital fund specialized on deep tech seed stage investments.
Excalibur Fund Managers
Excalibur Fund Managers is a venture capital firm specializing in early, mid, and late stage investments.
MVM Life Science Partners
MVM Life Science Partners is a venture capital firm specializing in investments in start-up, early stage, mid venture, late venture.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-10-06 | Affidea | Affidea acquired by Ares Life Sciences | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-12-05 | Broncus Technologies | Ares Life Sciences investment in Series G - Broncus Technologies | 38 M USD |
| 2008-11-06 | Santhera Pharmaceuticals | Ares Life Sciences investment in Post-IPO Equity - Santhera Pharmaceuticals | 15.9 M CHF |
More informations about "Ares Life Sciences"
Ares Life Sciences AG
Jan 1, 2008 Its strategy is to focus on key life sciences sectors, mainly: pharmaceuticals and biotechnology, medical diagnostics, and medical technology. Ares Life Sciences has a long …See details»
Ares Life Sciences investment portfolio | PitchBook
Ares Life Sciences General Information Company Description. Ares Life Sciences was a healthcare-focused investment firm that focuses on investment in companies operating in the life science, pharmaceutical, drug, biotechnology, …See details»
B-FLEXION (former Ares Life Sciences) - BioAlps
B-FLEXION is a private, entrepreneurial investment firm with offices across Europe and in the US. B-FLEXION invests in – and partners with – asset managers across sectors including Private …See details»
Ares Life Sciences - Investments, Portfolio & Company Exits
Ares Life Sciences 's most notable exits include Santhera Pharmaceuticals and Broncus Technologies. Which industries has this organization had the most exits in? Show . Santhera …See details»
Ares Life Sciences Fund: Performance - PitchBook
Dec 4, 2008 Ares Life Sciences Fund's latest investment was on 14-Jul-2014 in The Esaote Group, a company within the Diagnostic Equipment industry. Data Transparency. Meet our …See details»
Ares Life Sciences - CB Insights
Sep 8, 2015 Ares Life Sciences is a healthcare-focused investment group, whose financial backer is the Bertarelli family. Its strategy is to focus on key life sciences sectors, mainly: …See details»
Ares Life Sciences SA - Company Profile and News
Company profile page for Ares Life Sciences SA including stock price, company news, executives, board members, and contact informationSee details»
Ares Life Sciences to Purchase US Antigen Laboratories
Apr 16, 2013 Ares Life Sciences, an investment group focused on health care, announced its 100% acquisition of the share capital of Antigen Laboratories Inc’s wholly owned Planet …See details»
Ares Life Sciences to acquire US-based Antigen Laboratories
Apr 15, 2013 Ares Life Sciences, a Swiss healthcare-focused investment group, has agreed to acquire Planet Biopharmaceuticals, including its subsidiary Antigen Laboratories, a producer …See details»
Ares Life Sciences to Acquire GREER(R) Laboratories, Inc., a Leader …
Mar 8, 2013 Ares Life Sciences, a healthcare-focused investment group, announced today that it has signed a definitive agreement to acquire 100% of the share capital of Albion Medical …See details»
Ares Life Sciences Takes Over Planet Biopharmaceuticals
Apr 15, 2013 Ares Life Sciences signed a definitive agreement to acquire all the share capital of Planet Biopharmaceuticals, including its wholly owned subsidiary Antigen Laboratories. …See details»
Stallergenes proposes merger proposal with U.S. partner - Yahoo …
Mar 3, 2015 Under the terms of the transaction, Stallergenes shareholders would receive, through a cross-border merger, one share of Ares Allergy Holding, the British unit of Ares Life …See details»
Minority shareholders unite against terms of ... - Fierce Biotech
Apr 30, 2015 Ares Life Sciences has encountered resistance to its plan to merge Stallergenes and Greer. The investment funds own 77% of Stallergenes and all of Greer, but minority …See details»
Jacques Theurillat — Sofinnova Partners
In 2008, Jacques co-founded and managed Ares Life Sciences, a privately owned investment fund with the objective to build and manage a portfolio of companies in life sciences. Jacques …See details»
Recommended Cash Acquisition of Stallergenes Greer PLC by Ares …
Mar 21, 2019 The special committee of independent directors of Stallergenes Greer (Paris:STAGR) (the "Special Committee") and Ares Life Sciences I S.à r.l. ("Waypoint") are …See details»
Ares Life Sciences acquires Affidea - 2014-10-06 - Crunchbase
Oct 6, 2014 Acquired Organization: Affidea Affidea, the Pan-European provider of diagnostic imaging and cancer treatment services. Acquiring Organization: Ares Life Sciences Ares Life …See details»
Jacques Theurillat Profile: Contact Information & Network
He served as Chief Executive Officer at Ares Life Sciences. Mr. Theurillat also served as Chief Executive Officer, Chairman, and President at Albea Pharmaceuticals. He has been appointed …See details»
Ares Life Sciences - Tech Stack, Apps, Patents & Trademarks
Ares Life Sciences has 1 registered patent in the ' Organic Chemistry ' category, according to IPqwery. UNLOCK PREMIUM DATA WITH DATABOOST IT Spend by Aberdeen. Edit IT …See details»
Ares Life Sciences - BioCentury Company Profiles - BCIQ
Apr 6, 2015 Ares Life Sciences - BioCentury Company Profiles for the biopharma industrySee details»